BioSpace News Archive

Drug Development

Spago Nanomedical Publishes Scientific Paper on Positive Preclinical Data with Tumorad(R) as Treatment of Solid Tumors

Spago Nanomedical AB announced the publication of data on the composition, stability, and mode of action for its leading candidate drug 177Lu-SN201.

January 10, 2023
·
2 min read
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, a company which Prenetics recently acquired a majority stake in, has received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco, the company’s comprehensive genomic profiling test for solid tumors

January 10, 2023
·
5 min read
FDA

KRONOS® AIR DISINFECTION TECHNOLOGY MANUFACTURER RECEIVES FDA 510(K) CLASS II MEDICAL DEVICE CLEARANCE FOR THE DESTRUCTION OF VIRUSES, BACTERIA, AND ALLERGENS

KRONOS ADVANCED TECHNOLOGIES, INC. announced today that the U.S. Food and Drug Administration (FDA) has recently granted 510(k) clearance, classifying it as a Class II Medical Device.

January 10, 2023
·
10 min read
Business

Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced today that significant progress has been achieved in its collaboration with Evotec SE (FSE: EVT; NASDAQ: EVO).

January 10, 2023
·
7 min read
Drug Development

BrainStorm Cell Therapeutics Partners with NEALS, The ALS Association, and I AM ALS to Provide Public Access to Biospecimens from NurOwn’s Phase 3 ALS Study

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that BCLI will donate biospecimens from NurOwn’s placebo-controlled Phase 3 ALS trial to the Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) biorepository for use by the research community.

January 10, 2023
·
7 min read
Business

Foundation Medicine Announces Collaboration with Karyopharm Therapeutics to Develop FoundationOne®CDx as a Companion Diagnostic for XPOVIO® (selinexor)

Foundation Medicine Announces Collaboration with Karyopharm Therapeutics to Develop FoundationOne ® CDx as a Companion Diagnostic for XPOVIO® (selinexor).

January 10, 2023
·
4 min read
Deals

BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and InstaDeep Ltd. (“InstaDeep”) today announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of artificial intelligence (“AI”) and machine learning (“ML”).

January 10, 2023
·
10 min read
BioMidwest

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Medical Technology, Inc., released information regarding the success of the IMPASS Embolic Device in in-vivo research related to middle meningeal artery embolizations which can be used to treat chronic subdural hematomas on the surface of the brain.

January 10, 2023
·
2 min read
Business

GreenLab Names Jim Hedges as CEO

GreenLab, Inc. announces Jim Hedges as its new Chief Executive Officer.

January 10, 2023
·
2 min read
Biotech Beach

AEON Biopharma and Priveterra Acquisition Corp. Announce Additional Capital Commitment from Existing Investors for at Least $20 Million

AEON Biopharma, Inc. and Priveterra Acquisition Corp. today announced that at least $20 million in additional funding has been committed by existing AEON investors.

January 10, 2023
·
11 min read